Risk factors for death among cancer patients with fungemia

Clinical Infectious Diseases

Volumn 27, Issue 1, 1998, Pages 107-111

  Nucci, Marcio ^a   Silveira, Maria Isabel ^b   Spector, Nelson ^b   Silveira, Fernanda ^b   Velasco, Eduardo ^b   Akiti, Tiyonii ^b   Barreiros, Gloria ^b   Derossi, Andrea ^b   Colombo, Arnaldo L ^b   Pulcheri, Wolmar ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; STEROID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD CULTURE; CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANDIDA; CATHETERIZATION; CHILD; FEMALE; FUNGEMIA; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TOTAL PARENTERAL NUTRITION;

EID: 17344370807     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514609     Document Type: Article

References (10)

1. Beck-Sagué CM, Jarvis WR, the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993;167:1247-51.
2. Karabinis A, Hill C, Lecler CQB, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case control study. J Clin Microbiol 1988;26:429-32.
3. Wey SB, Mori M, Pfaller MA, et al. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-5.
4. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host. Am J Med 1981;71:363-70.
5. Kreger Van Rij NJW, ed. The yeasts, a taxonomic study. Amsterdam: Elsevier Science Publishers, 1984.
6. Karnofsky DA, Burchenot JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLead CM, ed. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949:191-205.
7. Walsh TJ, Pizzo PA. Treatment of systemic fungal infections: recent progress and current problems. Eur J Clin Microbiol Infect Dis 1988;7:460-75.
8. Banerjee AN, Emori G, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(suppl 3B):86S-9S.
9. Rex JH, Bennet JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-30.
10. Cooper BH, Silva-Hunter M. Yeasts of medical importance. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, 1985:526-41.